BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28393124)

  • 1. A
    Inêz-Ferreira TM; Mendoza L; Vilela R; Andrade HM; Haddad JP; Nunes FF; Gondim IM; Guimarães TM; de Toledo VP
    Heliyon; 2017 Mar; 3(3):e00278. PubMed ID: 28393124
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemically induced disseminated pythiosis in BALB/c mice: A new experimental model for Pythium insidiosum infection.
    Tondolo JSM; Loreto ÉS; Ledur PC; Jesus FPK; Silva TM; Kommers GD; Alves SH; Santurio JM
    PLoS One; 2017; 12(5):e0177868. PubMed ID: 28542438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells pulsed with Pythium insidiosum (1,3)(1,6)-β-glucan, Heat-inactivated zoospores and immunotherapy prime naïve T cells to Th1 differentiation in vitro.
    Ledur PC; Tondolo JSM; Jesus FPK; Verdi CM; Loreto ÉS; Alves SH; Santurio JM
    Immunobiology; 2018 Mar; 223(3):294-299. PubMed ID: 29074300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis.
    Mendoza L; Mandy W; Glass R
    Vaccine; 2003 Jun; 21(21-22):2797-804. PubMed ID: 12798620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-ADA activity in lymphocytes of an experimental model of pythiosis treated with immunotherapy.
    Bach BC; Leal DB; Jaques JA; Souza Vdo C; Ruchel JB; Schlemmer KB; Zanette RA; Hecktheuer PA; de Lima Pereira P; Casali EA; Alves SH; Santurio JM
    Cell Biochem Funct; 2013 Aug; 31(6):476-81. PubMed ID: 23086808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
    Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
    Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential anti-
    Yolanda H; Jearawuttanakul K; Wannalo W; Kanjanasirirat P; Borwornpinyo S; Rujirawat T; Payattikul P; Kittichotirat W; Wichadakul D; Krajaejun T
    Microbiol Spectr; 2024 Feb; 12(2):e0162023. PubMed ID: 38179943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal injection of Pythium insidiosum protein antigens for improved diagnosis and treatment of pythiosis in an experimental model.
    Weiblen C; Zanette RA; Ribeiro TC; Pereira Dos Santos CE; Ianiski LB; Pereira DIB; Santurio JM; Botton SA
    Med Mycol; 2019 Oct; 57(7):807-812. PubMed ID: 30260397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy based on Pythium insidiosum mycelia drives a Th1/Th17 response in mice.
    Tondolo JSM; Loreto ES; de Jesus FPK; Ledur PC; Verdi CM; Santurio JM
    Med Mycol; 2020 Nov; 58(8):1120-1125. PubMed ID: 32396166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective cytokine production from monocytes/macrophages of E-beta thalassemia patients in response to Pythium insidiosum infection.
    Ud-Naen S; Tansit T; Kanistanon D; Chaiprasert A; Wanachiwanawin W; Srinoulprasert Y
    Immunobiology; 2019 May; 224(3):427-432. PubMed ID: 30765134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic variation in the elicitin-like glycoprotein, ELI025, of Pythium insidiosum isolated from human and animal subjects.
    Lerksuthirat T; Lohnoo T; Rujirawat T; Yingyong W; Jongruja N; Krajaejun T
    Infect Genet Evol; 2015 Oct; 35():127-33. PubMed ID: 26254563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stryphnodendron adstringens and purified tannin on Pythium insidiosum: in vitro and in vivo studies.
    Trolezi R; Azanha JM; Paschoal NR; Chechi JL; Dias Silva MJ; Fabris VE; Vilegas W; Kaneno R; Fernandes Junior A; Bosco SM
    Ann Clin Microbiol Antimicrob; 2017 Feb; 16(1):7. PubMed ID: 28231795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron chelation therapy as a treatment for Pythium insidiosum in an animal model.
    Zanette RA; Alves SH; Pilotto MB; Weiblen C; Fighera RA; Wolkmer P; Flores MM; Santurio JM
    J Antimicrob Chemother; 2013 May; 68(5):1144-7. PubMed ID: 23329785
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Medhasi S; Sriwarom A; Permpalung N; Torvorapanit P; Plongla R; Chindamporn A; Worasilchai N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2304372. PubMed ID: 38314761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Pythium insidiosum by nested PCR in cutaneous lesions of Brazilian horses and rabbits.
    Botton SA; Pereira DI; Costa MM; Azevedo MI; Argenta JS; Jesus FP; Alves SH; Santurio JM
    Curr Microbiol; 2011 Apr; 62(4):1225-9. PubMed ID: 21188592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers.
    Iborra S; Abánades DR; Parody N; Carrión J; Risueño RM; Pineda MA; Bonay P; Alonso C; Soto M
    Clin Exp Immunol; 2007 Nov; 150(2):375-85. PubMed ID: 17900304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.